Sign in
4

Changes in Ownership

Larimar Therapeutics, Inc. Filed Acc 0001062993-22-012309

Options or other derivatives

  • President and CEO acquired 40,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
BEN-MAIMON CAROLE President and CEO 2022-05-10 Grant or award · Stock Option (Right to Buy) +40,000 40,000 D: show line 1 in the form
Loading xslF345X03/form4.xml…